• 1
    Matsushime H, Quelle D, Shurtleff S, Shibuya M, Sherr C, Kato J. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 1994; 14: 20662076.
  • 2
    Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14: 20772086.
  • 3
    Inaba T, Matsushime H, Valentine M, Roussel M, Sherr C, Look A. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 1992; 13: 565574.
  • 4
    Xiong Y, Menninger J, Beach D, Ward, D. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 1992; 13: 575584.
  • 5
    Ajchenbaum F, Ando K, DeCaprio, J, Griffin, J. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J Biol Chem 1993; 268: 41134119.
  • 6
    Tam S, Theodoras A, Shay J, Draetta G, Pagano M. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene 1994; 9: 26632674.
  • 7
    Juan G, Gong J, Traganos F, Darzynkiewicz Z. Unscheduled expression of cyclins D1 and D3 in human tumour cell lines. Cell Prolif 1996; 29: 259266.
  • 8
    Ragione F, Borriello A, Mastropietro S, Pietra V, Monno F, Gabutti V, Locatelli F, Bonsi L, Bagnara G, Iolascon A. Expression of G1-phase cell cycle genes during hematopoietic lineage. Biochem Biophys Res Commun 1997; 231: 7376.
  • 9
    Wagner E, Hleb M, Hanna N, Sharma, S. A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10–mediated human B cell proliferation. J Immunol 1998; 161: 11231131.
  • 10
    Komatsu H, Iida S, Yamamoto K, Mikuni C, Nitta M, Takahasi T, Ueda R, Seto M. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. Blood 1994; 84: 12261231.
  • 11
    Rosenberg C, Wong E, Petty E, Bale A, Tsuimoto Y, Harris N, Arnold A. PRAD1, a candidate BCL-1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 191; 88: 96389642.
  • 12
    Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54: 18121817.
  • 13
    McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TW, Horne CH. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995; 11: 885891.
  • 14
    Wang T, Cardiff R, Zukerberg L, Lees E, Arnold A, Schmidt E. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994; 269: 669671.
  • 15
    Yu, Q, Sicinski, P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001; 411: 10171021.
  • 16
    Van Dyk L, Virgin H, Speck, S. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J Virol 2000; 74: 74517461.
  • 17
    Russo J, Bohenzky R, Chien M, Cehn J, Yan M, Daddalena D, Parry J, Peruzzi D, Edelman I, Cahng Y, Moore P. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996; 93: 1486214867.
  • 18
    Jung J, Stager M, Desrosiers R. Virus-encoded cyclin. Mol Cell Biol 1994; 14: 72357244.
  • 19
    Nicholas J, Cameron K, Honess R. Herpesvirus saimiri encodes homologs of G protein-coupled receptors and cyclins. Nature 1992; 355: 362365.
  • 20
    Swanton C, Mann D, Fleckenstein B, Neipel F, Peters G, Jones N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 1997; 390: 184187.
  • 21
    Kaplan, D, Smith, D. Enzymatic amplification staining for flow cytometric analysis of cell surface molecules. Cytometry 2000; 40: 8185.
  • 22
    Kaplan D, Smith D, Meyerson H, Pecora N, Lewandowska K. CD5 expression by B lymphocytes and its regulation upon Epstein-Barr Virus transformation. Proc Natl Acad Sci USA 2001; 98: 1385013854.
  • 23
    Kaplan, D, Meyerson H, Lewandowska, K. High resolution immunophenotypic analysis of chronic lymphocytic leukemia cells by enzymatic amplification staining (EAS). Am J Clin Pathol 2001; 116: 429436.
  • 24
    Kaplan, D. Flow cytometric analysis of cells from persons with HIV-1 disease by enzymatic amplification staining (EAS). In: CossarizzaA, KaplanD, editors. Cellular aspects of HIV infection. New York: Wiley-Liss; 2001. p 351369.
  • 25
    Kaplan D, Husel WH, Meyerson H. Immunophenotypic analysis with enhanced sensitivity of detection by enzymatic amplification staining (EAS). Clin Lab Med 2001; 21: 763778.
  • 26
    Kaplan D, Smith D. Ultra-sensitive detection of cell surface molecules by enzymatic amplification staining and flow cytometry. In: MasonD editor. Leucocyte typing VII. New York: Oxford University Press; 2002. p 402403.
  • 27
    Meyerson H, Kaplan D. Applications of enzymatic amplification in immunophenotyping. Front Biosci 2002; 7: 3343.
  • 28
    Kaplan D, Husel W, Lewandowska K. CD34 expression on platelets. Platelets 2003; 14: 8387.
  • 29
    Kaplan D. Enzymatic amplification staining for cell surface antigens. In: RobinsonJP, editor. Current protocols in cytometry. New York: Wiley; 2003. p
  • 30
    Kaplan D. Enzymatic amplification staining for single cell analysis: applied to in situ hybridization. J Immunol Methods 2003; 283: 17.
  • 31
    Jabara H, Broder SR, Geha R. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J Clin Invest 2001; 107: 371378.
  • 32
    Liu X, Bai X, Wen J, Gao J, Liu J, Lu P, Wang Y, Zheng P, Liu Y. B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8+ T lymphocytes in vivo. J Exp Med 2001; 194: 13391348.
  • 33
    Bernard J, Treton D, Vermot-Desroches C, Boden C, Horellou P, Angevin E, Galanaud P, Wijdenes J, Richard Y. Expression of Interleukin 13 receptor in glioma and renal cell carcinoma: IL13Rα2 as a decoy receptor for IL13. Lab Invest 2001; 81: 12231231.
  • 34
    Horner A, Widhopf G, Burger J, Takabayashi K, Cinman N, Ronaghy A, Spiegelberg H, Raz E. Immunostimulatory DNA inhibits IL-4–dependent IgE synthesis by human B cells. J Allergy Clin Immunol 2001; 108: 417423.
  • 35
    Kennedy N, Russell J, Michail N, Budd R. Liver damage by infiltrating CD8+ cells is Fas dependent. J Immunol 2001; 167: 66546662.
  • 36
    Otsu M, Hershfield M, Tuschong L, Muul L, Onodera M, Ariga T, Sakiyama Y, Candotti F. Flow cytometric analysis of adenosine deaminase (ADA) expression: a simple and reliable tool for the assessment of ADA-deficient patients before and after gene therapy. Hum Gene Ther 2002; 13: 425432.
  • 37
    Boursalian T, Fink, P. Mutation in Fas ligand impairs maturation of thymocytes bearing moderate affinity T cell receptors. J Exp Med 2003; 198: 349360.
  • 38
    Mintz A, Gibo D, Slagle B, Webb B, Christensen N, Debinski, W. IL-13Rα2 is a glioma-restricted receptor for interleukin-13. Neoplasia 2002; 4: 388399.
  • 39
    Roessner K, Wolfe J, Shi C, Sigal L, Huber S, Budd R. High expression of Fas ligand by synovial fluid-derived γδ T cells in Lyme arthritis. J Immunol 2003; 170: 27022710.
  • 40
    Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 1994; 9: 707718.
  • 41
    Yamada H, Iwase S, Nagai M, Nemoto T, Sekikawa T, Takahara S, Nakada S, Furukawa Y, Horiguchi-Yamda J. Herbimycin A down-regulates messages of cyclin D1 and c-myc during erythroid differentiation of K562 cells. Int J Hematol 1996; 65: 3140.
  • 42
    Sonoyama J, Matsumura I, Ezoe S, Satoh Y, Zhang X, Kataoka Y, Takai E, Mizuki M, Machii T, Wakao H, Kanakura Y. Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells. J Biol Chem 2002; 277: 80768082.
  • 43
    Wu Y, Pan S, Che S, He G, Nelman-Gonzalez M, Wil M, Kuang J. Overexpression of Hp95 induces G1 phase arrest in confluent HeLa cells. Differentiation 2000; 67: 139153.
  • 44
    Howe D, Lynas, C. The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Hematologica 2001; 86: 563569.
  • 45
    Dong F, Cress D, Agrawal D, Pledger W. The role of cyclin D3-dependent kinase in the phosphorylation of p130 in mouse BALB/c 3T3 fibroblasts. J Biol Chem 1998; 273: 61906195.
  • 46
    Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993; 7: 812821.
  • 47
    Diehl A, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3 regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12: 34993511.
  • 48
    Adachi M, Ito H, Surejkanchanakij P, Adachi S, Hiroe M, Shimizu M, Kawauchi J, Sunamori M, Marumo F, Kitajima S, Ikeda M. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ Res 2003; 92: e12e19.
  • 49
    Lazzereschi D, Sambuco L, Scalzo C, Ranieri A, Minicione G, Nardi F, Colletta G. Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas. Int J Cancer 1998; 76: 806811.
  • 50
    Diehl A, Sherr CJ. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol Cell Biol 1997; 17: 73627374.
  • 51
    Alt J, Cleveland J, Hannink M, Diehl A. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 2000; 14: 31023114.
  • 52
    Won K, Xiong Y, Beach D, Gilman M. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci USA 1992; 89: 99109914.
  • 53
    Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F. Cytometry of cyclin proteins. Cytometry 1996; 25: 113.
  • 54
    Gong J, Bhatia U, Traganos F, Darzynkiewicz Z. Expression of cyclins A, D2, and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry. Leukemia 1995; 9: 893899.
  • 55
    Nagasawa M, Melamed I, Kupfer A, Gelfand E, Lucas J. Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation. J Immunol 1997; 158: 51465154.
  • 56
    Neumeister, P, Pixley FJ, Xiong Y, Xie H, Wu K, Ashton A, Cammer M, Chan A, Symons M, Stanley ER, Pestell RG. Cyclin D1 governs adhesion and motility of macrophages. Mol Biol Cell 2003; 14: 20052015.
  • 57
    Veiga-Fernandes H, Rocha B. High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. Nat Immunol 2004; 5: 3137.
  • 58
    Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, Yamaguchi M, Tamaru J, Uike N, Hashimoto Y, Morishima Y, Suchi T Seto M, Nakamura S. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 2000; 95: 22532261.